Investigating how astrocytes affect brain function in Alzheimer's disease.

Project 3 - Astrocytic glutamate dysregulation in AD and VCID

NIH-funded research University of Kentucky · NIH-10897080

This study is looking at a protein called EAAT2/Glt-1 in brain cells to see how it affects brain health in people with Alzheimer's and similar conditions, hoping to find new ways to help improve treatments for memory and thinking problems.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionUniversity of Kentucky NIH-funded
Lab location1 site (Lexington, United States)
Project IDNIH-10897080 on NIH RePORTER

What this research studies

This research focuses on understanding the role of a specific protein, EAAT2/Glt-1, in astrocytes and its impact on brain health in Alzheimer's disease and related dementias. Researchers will explore how reduced levels of this protein affect blood vessel function, brain metabolism, and neural activity. By studying these mechanisms, the research aims to uncover how astrocytes contribute to the progression of Alzheimer's and potentially identify new therapeutic targets. Patients may benefit from insights that could lead to improved treatments for cognitive decline.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not receive benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating or preventing cognitive decline in Alzheimer's disease and related dementias.

How similar studies have performed: Previous research has shown promising results in targeting astrocyte functions in other neurological conditions, suggesting potential for success in this area as well.

Where this research is happening

Lexington, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.